| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
National Health Investors, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$58.50 |
| 52 Week High | US$58.50 |
| 52 Week Low | US$43.20 |
| Beta | 0.98 |
| 1 Month Change | 3.54% |
| 3 Month Change | 17.47% |
| 1 Year Change | 30.58% |
| 3 Year Change | -2.50% |
| 5 Year Change | -13.02% |
| Change since IPO | 176.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| WX6 | DE Health Care REITs | DE Market | |
|---|---|---|---|
| 7D | 3.5% | 0% | 0% |
| 1Y | 30.6% | 0% | 0% |
Return vs Industry: WX6 exceeded the German Health Care REITs industry which returned -19.1% over the past year.
Return vs Market: WX6 exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| WX6 volatility | |
|---|---|
| WX6 Average Weekly Movement | 3.2% |
| Health Care REITs Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in DE Market | 0% |
| 10% least volatile stocks in DE Market | 0% |
Stable Share Price: WX6 has not had significant price volatility in the past 3 months.
Volatility Over Time: WX6's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 27 | D. Mendelsohn | www.nhireit.com |
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
National Health Investors, Inc. Fundamentals Summary
| WX6 fundamental statistics | |
|---|---|
| Market cap | €2.55b |
| Earnings (TTM) | €126.62m |
| Revenue (TTM) | €299.18m |
20.1x
P/E Ratio8.5x
P/S RatioIs WX6 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WX6 income statement (TTM) | |
|---|---|
| Revenue | US$320.39m |
| Cost of Revenue | US$11.51m |
| Gross Profit | US$308.88m |
| Other Expenses | US$173.28m |
| Earnings | US$135.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 06, 2024
| Earnings per share (EPS) | 3.12 |
| Gross Margin | 96.41% |
| Net Profit Margin | 42.32% |
| Debt/Equity Ratio | 89.1% |
How did WX6 perform over the long term?
See historical performance and comparison